37 related articles for article (PubMed ID: 31066459)
1. Role of the DEK oncogene in the development of squamous cell carcinoma.
Ishida K; Nakashima T; Shibata T; Hara A; Tomita H
Int J Clin Oncol; 2020 Sep; 25(9):1563-1569. PubMed ID: 32656741
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin induces prolonged DNA damage signal in cells overexpressing DEK isoform-2.
Özçelik E; Kalaycı A; Çelik B; Avcı A; Akyol H; Kılıç İB; Güzel T; Çetin M; Öztürk MT; Çalışkaner ZO; Tombaz M; Yoleri D; Konu Ö; Kandilci A
PLoS One; 2022; 17(10):e0275476. PubMed ID: 36190960
[TBL] [Abstract][Full Text] [Related]
3. Crowberry inhibits cell proliferation and migration through a molecular mechanism that includes inhibition of DEK and Akt signaling in cholangiocarcinoma.
Wang X; Zhou X; Zhang L; Zhang X; Yang C; Piao Y; Zhao J; Jin L; Jin G; An R; Ren X
Chin Med; 2022 Jun; 17(1):69. PubMed ID: 35698073
[TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA NR2F1-AS1 Enhances the Migration and Invasion of Hepatocellular Carcinoma via Modulating miR-642a/DEK Pathway.
Xu Y; Han C; Sun J; Zhao J; Liu Q; An P
J Oncol; 2021; 2021():6868514. PubMed ID: 34594378
[TBL] [Abstract][Full Text] [Related]
5. The role of mediator complex subunit 19 in human diseases.
Zhang Y; Qin P; Tian L; Yan J; Zhou Y
Exp Biol Med (Maywood); 2021 Aug; 246(15):1681-1687. PubMed ID: 34038190
[TBL] [Abstract][Full Text] [Related]
6. DEK is highly expressed in breast cancer and is associated with malignant phenotype and progression.
Yang MQ; Bai LL; Wang Z; Lei L; Zheng YW; Li ZH; Huang WJ; Liu CC; Xu HT
Oncol Lett; 2021 Jun; 21(6):440. PubMed ID: 33868478
[TBL] [Abstract][Full Text] [Related]
7. MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK.
Zhang W; Liao K; Liu D
Cancer Manag Res; 2020; 12():8137-8147. PubMed ID: 32982411
[TBL] [Abstract][Full Text] [Related]
8. DEK Expression in Breast Cancer Cells Leads to the Alternative Activation of Tumor Associated Macrophages.
Pease NA; Shephard MS; Sertorio M; Waltz SE; Vinnedge LMP
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708944
[TBL] [Abstract][Full Text] [Related]
9. The unique DEK oncoprotein in women's health: A potential novel biomarker.
de Albuquerque Oliveira AC; Kappes F; Martins DBG; de Lima Filho JL
Biomed Pharmacother; 2018 Oct; 106():142-148. PubMed ID: 29957464
[TBL] [Abstract][Full Text] [Related]
10. The Complexity of DEK Signaling in Cancer Progression.
Teng Y; Lang L; Jauregui CE
Curr Cancer Drug Targets; 2018; 18(3):256-265. PubMed ID: 28530531
[TBL] [Abstract][Full Text] [Related]
11. High expression of DEK is associated with poor prognosis in hepatocellular carcinoma.
Lee SY; Jung W; Lee J; Kim A; Kim HK; Kim BH
Histol Histopathol; 2019 Nov; 34(11):1279-1288. PubMed ID: 31066459
[TBL] [Abstract][Full Text] [Related]
12. Critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma.
Yu L; Huang X; Zhang W; Zhao H; Wu G; Lv F; Shi L; Teng Y
Oncotarget; 2016 May; 7(18):26844-55. PubMed ID: 27057626
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma.
Yi HC; Liu YL; You P; Pan JS; Zhou JY; Liu ZJ; Zhang ZY
Mol Med Rep; 2015 Feb; 11(2):1318-23. PubMed ID: 25351213
[TBL] [Abstract][Full Text] [Related]
14. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L
Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610
[TBL] [Abstract][Full Text] [Related]
15. DEK oncogene is overexpressed during melanoma progression.
Riveiro-Falkenbach E; Ruano Y; García-Martín RM; Lora D; Cifdaloz M; Acquadro F; Ballestín C; Ortiz-Romero PL; Soengas MS; Rodríguez-Peralto JL
Pigment Cell Melanoma Res; 2017 Mar; 30(2):194-202. PubMed ID: 27893188
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
